Merge branch 'main' into extract/2025-05-01-doodles-dood-token-entertainment-brand-pivot

domains/entertainment/creator-owned-streaming-infrastructure-has-reached-commercial-scale-with-430M-annual-creator-revenue-across-13M-subscribers.md

@@ -44,6 +44,12 @@ Dropout reached 1M+ subscribers by October 2025. Nebula revenue more than double
 
 Dropout specifically generates $80-90M annual revenue with 1M+ subscribers, representing 18-21% of the total $430M creator-owned streaming market. This single-platform data point confirms the category-level aggregates and provides unit economics: $80-90 ARPU, 40-45% EBITDA margins, $3.0-3.3M revenue per employee.
 
+
+### Additional Evidence (extend)
+*Source: [[2025-10-01-variety-dropout-superfan-tier-1m-subscribers]] | Added: 2026-03-16*
+
+Dropout crossed 1M paid subscribers in October 2025 with 31% YoY growth, representing ARR 'north of $30M' at 40-45% EBITDA margins. This adds a major data point: single creator-owned platform now at $30M+ ARR with 40 employees (~$750K revenue per employee), confirming the commercial viability at scale.
+
 ---
 
 Relevant Notes:

domains/entertainment/creator-owned-streaming-uses-dual-platform-strategy-with-free-tier-for-acquisition-and-owned-platform-for-monetization.md

@@ -23,6 +23,12 @@ This dual-platform architecture solves the discovery problem that pure owned-pla
 - All three platforms serve niche audiences with high willingness-to-pay
 - Community-driven discovery model supplements (not replaces) algorithmic discovery
 
+
+### Additional Evidence (confirm)
+*Source: [[2025-10-01-variety-dropout-superfan-tier-1m-subscribers]] | Added: 2026-03-16*
+
+Dropout maintains YouTube presence (15M+ subscribers from CollegeHumor era) for discovery while Dropout.tv serves as monetization platform. Game Changer Season 7 premiere reached 1M views in 2 weeks, showing continued YouTube distribution alongside owned platform growth to 1M paid subscribers.
+
 ---
 
 Relevant Notes:

domains/entertainment/indie-streaming-platforms-emerged-as-category-by-2024-with-convergent-structural-patterns-across-content-verticals.md

@@ -30,6 +30,12 @@ The timing matters: this is the first major entertainment trade publication to a
 - Shared characteristics: creator ownership, niche audiences, community-driven growth, dual-platform strategy
 - Trade press category recognition typically lags market formation by 12-24 months
 
+
+### Additional Evidence (extend)
+*Source: [[2025-10-01-variety-dropout-superfan-tier-1m-subscribers]] | Added: 2026-03-16*
+
+Critical Role's Beacon launched May 2024 at $5.99/month and experienced ~20% Twitch subscriber migration post-launch, showing owned platform adoption even for established creators with large platform audiences. Beacon and Dropout now collaborating on talent (Brennan Lee Mulligan) rather than competing.
+
 ---
 
 Relevant Notes:

domains/entertainment/youtube-first-distribution-for-major-studio-coproductions-signals-platform-primacy-over-traditional-broadcast-windowing.md

@@ -35,6 +35,12 @@ This is one data point from one studio. The claim is experimental because it's b
 
 The Claynosaurz-Mediawan co-production will launch on YouTube first, then sell to TV and streaming buyers. This inverts the traditional risk model: YouTube launch proves audience metrics before traditional buyers commit, using the community's existing social reach (~1B views) as a guaranteed launch audience. Mediawan brings professional production quality while the community provides distribution validation, creating a new risk-sharing structure where platform distribution precedes rather than follows traditional media deals.
 
+
+### Additional Evidence (extend)
+*Source: [[2025-02-01-deadline-pudgy-penguins-youtube-series]] | Added: 2026-03-16*
+
+Pudgy Penguins chose to launch Lil Pudgys on its own YouTube channel (13K subscribers) rather than leveraging TheSoul Publishing's 2B+ follower distribution network. This extends the claim by showing that YouTube-first distribution can mean building a DEDICATED brand channel rather than parasitizing existing platform reach. The decision prioritizes brand ownership over reach maximization, suggesting YouTube-first is not just about platform primacy but about audience ownership architecture.
+
 ---
 
 Relevant Notes:

domains/health/AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk.md

@@ -25,6 +25,30 @@ This adoption velocity matters beyond documentation itself. AI scribes are the b
 
 The contrast is instructive: since [[medical LLM benchmark performance does not translate to clinical impact because physicians with and without AI access achieve similar diagnostic accuracy in randomized trials]], clinical AI faces a trust and integration gap that documentation AI has already crossed. The lesson is that healthcare AI adoption follows the path of least institutional resistance, not the path of greatest clinical potential.
 
+
+### Additional Evidence (extend)
+*Source: [[2025-06-01-abridge-valuation-growth-ai-scribe-metrics]] | Added: 2026-03-16*
+
+Abridge's clinical outcomes data shows 73% reduction in after-hours documentation time, 61% reduction in cognitive burden, and 81% improvement in workflow satisfaction. The company won top ambient AI slot in 2025 KLAS annual report and deployed across 150+ health systems including Kaiser (24,600 physicians), Mayo Clinic (2,000+ physicians enterprise-wide), Johns Hopkins, Duke, UPMC, and Yale New Haven. This represents the transition from pilot adoption to enterprise-wide deployment at scale.
+
+
+### Additional Evidence (challenge)
+*Source: [[2025-06-01-abridge-valuation-growth-ai-scribe-metrics]] | Added: 2026-03-16*
+
+Epic launched AI Charting in February 2026, creating an immediate commoditization threat to standalone ambient AI platforms. Abridge's response - pivoting to 'more than a scribe' positioning with coding, prior auth automation, and clinical decision support - suggests leadership recognized the documentation beachhead may not be defensible against EHR-native solutions. The timing of this strategic pivot (2025-2026) indicates the scribe adoption success may have a shorter durability window than the 92% adoption figure suggests.
+
+
+### Additional Evidence (challenge)
+*Source: [[2026-01-01-bvp-state-of-health-ai-2026]] | Added: 2026-03-16*
+
+The 92% figure applies to 'deploying, implementing, or piloting' ambient AI as of March 2025, not active deployment. This includes very early-stage pilots. The scope distinction between pilot programs and daily clinical workflow integration is significant — the claim may overstate actual adoption if interpreted as active use rather than organizational commitment to explore the technology.
+
+
+### Additional Evidence (extend)
+*Source: [[2026-03-11-wvu-abridge-rural-health-systems-expansion]] | Added: 2026-03-16*
+
+WVU Medicine expanded Abridge ambient AI across 25 hospitals including rural facilities in March 2026, one month after Epic AI Charting launch. This rural expansion suggests ambient AI has passed from pilot phase to broad deployment phase, as enterprise technology typically enters academic medical centers first, then regional health systems, then rural/critical access hospitals last. The fact that a state academic health system serving one of the most rural and medically underserved states chose to expand Abridge post-Epic launch provides implicit market validation of Abridge's competitive position.
+
 ---
 
 Relevant Notes:

domains/health/AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output.md

@@ -26,6 +26,18 @@ The implication for the healthcare attractor state: since [[the healthcare attra
 
 Since [[healthcares defensible layer is where atoms become bits because physical-to-digital conversion generates the data that powers AI care while building patient trust that software alone cannot create]], the most defensible AI-native health companies will be those that control both the data generation (atoms) and the AI processing (bits), not pure-play AI software companies layered onto someone else's clinical data.
 
+
+### Additional Evidence (confirm)
+*Source: [[2025-06-01-abridge-valuation-growth-ai-scribe-metrics]] | Added: 2026-03-16*
+
+Abridge reached $100M ARR with 150+ health system customers by May 2025, achieving $5.3B valuation. This represents the clearest real-world validation of AI-native productivity claims in healthcare - a documentation platform scaling to 9-figure revenue without the linear headcount scaling that would be required for traditional medical transcription or documentation services.
+
+
+### Additional Evidence (confirm)
+*Source: [[2026-01-01-bvp-state-of-health-ai-2026]] | Added: 2026-03-16*
+
+BVP reports AI-native healthcare companies achieve $500K-$1M+ ARR per FTE with 70-80%+ software-like margins, compared to $100-200K for traditional healthcare services and $200-400K for pre-AI healthcare SaaS. This is the primary source for the productivity claim, providing the specific ranges that support the 3-5x multiplier.
+
 ---
 
 Relevant Notes:

domains/health/GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md

@@ -61,16 +61,28 @@ The Trump Administration's Medicare GLP-1 deal establishes $245/month pricing (8
 
 
 ### Additional Evidence (challenge)
-*Source: [[2025-07-01-sarcopenia-glp1-muscle-loss-elderly-risk]] | Added: 2026-03-16*
+*Source: 2025-07-01-sarcopenia-glp1-muscle-loss-elderly-risk | Added: 2026-03-16*
 
 The sarcopenic obesity mechanism creates a pathway where GLP-1s may INCREASE healthcare costs in elderly populations: muscle loss during treatment + high discontinuation (64.8% at 1 year) + preferential fat regain = sarcopenic obesity → increased fall risk, fractures, disability, and long-term care needs. This directly challenges the Medicare cost-savings thesis by creating NEW healthcare costs (disability, falls, fractures) that may offset cardiovascular and metabolic savings.
 
 
 ### Additional Evidence (extend)
-*Source: [[2025-12-01-who-glp1-global-guidelines-obesity]] | Added: 2026-03-16*
+*Source: 2025-12-01-who-glp1-global-guidelines-obesity | Added: 2026-03-16*
 
 WHO issued conditional recommendations (not full endorsements) for GLP-1s in obesity treatment, explicitly acknowledging 'limited long-term evidence.' The conditional framing signals institutional uncertainty about durability of outcomes and cost-effectiveness at population scale. WHO requires countries to 'consider local cost-effectiveness, budget impact, and ethical implications' before adoption, suggesting the chronic use economics remain unproven for resource-constrained health systems.
 
+
+### Additional Evidence (challenge)
+*Source: 2025-01-01-jmir-digital-engagement-glp1-weight-loss-outcomes | Added: 2026-03-16*
+
+Danish cohort achieved same weight loss outcomes (16.7% at 64 weeks) using HALF the typical semaglutide dose when paired with digital behavioral support, matching clinical trial results at 50% drug cost. If this half-dose protocol proves generalizable, it could fundamentally alter the inflationary cost trajectory by reducing per-patient drug spending while maintaining efficacy.
+
+
+### Additional Evidence (extend)
+*Source: [[2026-02-01-cms-balance-model-details-rfa-design]] | Added: 2026-03-16*
+
+BALANCE Model's dual payment mechanism (capitation adjustment + reinsurance) plus manufacturer-funded lifestyle support represents the first major policy attempt to address the chronic-use cost structure. The Medicare GLP-1 Bridge (July 2026) provides immediate price relief while full model architecture is built, indicating urgency around cost containment.
+
 ---
 
 Relevant Notes:

domains/health/ambient AI documentation reduces physician documentation burden by 73 percent but the relationship between automation and burnout is more complex than time savings alone.md

@@ -19,6 +19,12 @@ In February 2026, Epic launched native AI Charting -- its own ambient scribe bui
 
 Wachter (UCSF Chair of Medicine) describes AI scribes as "the first technology we've brought into health care, maybe with the exception of video interpreters, where everybody says this is fantastic." The behavioral shift is immediate and visible: physicians put their phone down, tell patients they're recording, and make eye contact for the first time since EHR adoption. Wachter frames this as reclaiming "the humanity of the visit" -- the physician is no longer "pecking away" at a screen. This is notable because it inverts the EHR's original failure: the electronic health record digitized data but enslaved physicians to typing, creating the burned-out, screen-staring doctor that patients have endured for a decade. AI scribes fix the harm that the previous technology wave created.
 
+
+### Additional Evidence (extend)
+*Source: [[2026-03-11-wvu-abridge-rural-health-systems-expansion]] | Added: 2026-03-16*
+
+Rural hospitals face severe physician workforce shortages where documentation burden disproportionately affects rural providers who lack the staffing depth of academic medical centers. WVU Medicine's deployment across rural facilities suggests ambient AI may address physician retention in underserved areas by reducing the administrative burden that drives rural physician burnout. This extends the burnout relationship beyond time savings to workforce retention in resource-constrained settings.
+
 ---
 
 Relevant Notes:

domains/health/glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics.md

@@ -55,10 +55,22 @@ The $50/month out-of-pocket maximum for Medicare beneficiaries (starting April 2
 
 
 ### Additional Evidence (extend)
-*Source: [[2025-07-01-sarcopenia-glp1-muscle-loss-elderly-risk]] | Added: 2026-03-16*
+*Source: 2025-07-01-sarcopenia-glp1-muscle-loss-elderly-risk | Added: 2026-03-16*
 
 The discontinuation problem is worse than just lost metabolic benefits - it creates a body composition trap. Patients who discontinue lose 15-40% of weight as lean mass during treatment, then regain weight preferentially as fat without muscle recovery. This means the most common outcome (discontinuation) leaves patients with WORSE body composition than baseline: same or higher fat, less muscle, higher disability risk. Weight cycling on GLP-1s is not neutral - it's actively harmful.
 
+
+### Additional Evidence (extend)
+*Source: 2025-01-01-jmir-digital-engagement-glp1-weight-loss-outcomes | Added: 2026-03-16*
+
+Digital behavioral support may partially solve the persistence problem: UK study showed 11.53% weight loss with engagement vs 8% without at 5 months, suggesting the adherence paradox has a behavioral solution component. However, high withdrawal rates in non-engaged groups suggest this requires active participation, not passive app access.
+
+
+### Additional Evidence (extend)
+*Source: [[2026-02-01-cms-balance-model-details-rfa-design]] | Added: 2026-03-16*
+
+BALANCE Model's manufacturer-funded lifestyle support requirement directly addresses the persistence problem by mandating evidence-based programs for GI side effects, nutrition, and physical activity—the factors most associated with discontinuation. This shifts the cost of adherence support from payers to manufacturers.
+
 ---
 
 Relevant Notes:

domains/health/healthcare AI funding follows a winner-take-most pattern with category leaders absorbing capital at unprecedented velocity while 35 percent of deals are flat or down rounds.md

@@ -19,6 +19,12 @@ The emerging consensus: healthcare AI is a platform shift, not a bubble, but the
 
 **Bessemer corroboration (January 2026):** 527 VC deals in 2025 totaling an estimated $14B deployed. Average deal size increased 42% year-over-year (from $20.7M to $29.3M). Series D+ valuations jumped 63%. AI companies captured 55% of health tech funding (up from 37% in 2024). For every $1 invested in AI broadly, $0.22 goes to healthcare AI — exceeding healthcare's 18% GDP share. The Health Tech 2.0 IPO wave produced 6 companies with $36.6B combined market cap, averaging 67% annualized revenue growth. Health tech M&A hit 400 deals in 2025 (up from 350 in 2024), with strategic acquirers consolidating AI capabilities.
 
+
+### Additional Evidence (confirm)
+*Source: [[2026-01-01-bvp-state-of-health-ai-2026]] | Added: 2026-03-16*
+
+Abridge raised $300M Series E at $5B valuation and Ambiance raised $243M Series C at $1.04B valuation by early 2026, demonstrating the capital concentration in category leaders. Function Health's $300M Series C at $2.2B valuation further confirms winner-take-most dynamics in health AI.
+
 ---
 
 Relevant Notes:

domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md

@@ -37,16 +37,22 @@ Medicare Advantage plans bearing full capitated risk increased GLP-1 prior autho
 
 
 ### Additional Evidence (extend)
-*Source: [[2025-03-17-norc-pace-market-assessment-for-profit-expansion]] | Added: 2026-03-16*
+*Source: 2025-03-17-norc-pace-market-assessment-for-profit-expansion | Added: 2026-03-16*
 
 PACE represents the 100% risk endpoint—full capitation for all medical, social, and psychiatric needs, entirely replacing Medicare and Medicaid cards. Yet even at full risk with proven outcomes for the highest-cost patients, PACE serves only 0.13% of Medicare eligibles after 50 years. This suggests the stall point is not just at the payment boundary (partial vs full risk) but at the scaling boundary—capital, awareness, regulatory, and operational barriers prevent even successful full-risk models from achieving market penetration. The gap between 14% bearing full risk and PACE's 0.13% penetration indicates that moving from partial to full risk is necessary but insufficient for VBC transformation.
 
 
 ### Additional Evidence (extend)
-*Source: [[2025-12-23-cms-balance-model-glp1-obesity-coverage]] | Added: 2026-03-16*
+*Source: 2025-12-23-cms-balance-model-glp1-obesity-coverage | Added: 2026-03-16*
 
 The BALANCE Model moves payment toward genuine risk by adjusting capitated rates for obesity and increasing government reinsurance for participating MA plans. This creates a direct financial incentive mechanism where plans profit from preventing obesity-related complications rather than just managing them. The model explicitly tests whether combining medication access with lifestyle supports under risk-bearing arrangements can shift the payment boundary.
 
+
+### Additional Evidence (extend)
+*Source: [[2026-02-01-cms-balance-model-details-rfa-design]] | Added: 2026-03-16*
+
+CMS BALANCE Model demonstrates policy recognition of the VBC misalignment by implementing capitation adjustment (paying plans MORE for obesity coverage) plus reinsurance (removing tail risk) rather than expecting prevention incentives to emerge from capitation alone. This is explicit structural redesign around the identified barriers.
+
 ---
 
 Relevant Notes:

entities/entertainment/claynosaurz.md

@@ -25,6 +25,7 @@ Community-driven animated IP founded by former VFX artists from Sony Pictures, A
 - **2025-10-01** — Announced 39-episode animated series (7 min each) launching YouTube-first with Method Animation (Mediawan) co-production, followed by TV/streaming sales. Gameloft mobile game in co-development. Community has generated nearly 1B social views. Nic Cabana presented creator-led transmedia strategy at VIEW Conference.
 - **2025-10-01** — Nic Cabana presented at VIEW Conference on creator-led transmedia strategy. Announced 39 x 7-minute animated series co-produced with Method Animation (Mediawan), launching YouTube-first before traditional distribution. Community has generated nearly 1B social views. Gameloft mobile game in co-development. Shared achievement system planned across gaming, social media, collectibles, and community.
 - **2025-10-01** — Nic Cabana presented Claynosaurz transmedia strategy at VIEW Conference. Announced 39 x 7-minute animated series launching YouTube-first with Method Animation (Mediawan) co-production. Community has generated nearly 1B social views. Gameloft mobile game in co-development. Strategy uses shared achievement system integrating gaming, social media, collectibles, and community.
+- **2025-11-01** — Presented at MIPJunior 2025 (Cannes) detailing informal co-creation governance model with 450M+ views, 530K+ subscribers, 39-episode series in production with Mediawan Kids & Family, Gameloft mobile game in co-development
 ## Relationship to KB
 
 - Implements [[fanchise management is a stack of increasing fan engagement from content extensions through co-creation and co-ownership]] through specific co-creation mechanisms

entities/entertainment/dropout.md

@@ -22,6 +22,7 @@ Creator-owned streaming platform focused on comedy content. Reached 1M+ subscrib
 - **2025-10-XX** — Reached 1M+ subscribers milestone
 
 - **2026-03-01** — CVL Economics analysis reveals 1M+ subscribers generating $80-90M revenue with 40-45% EBITDA margins and 40 full-time employees, achieving $3.0-3.3M revenue per employee. Platform maintains stable pricing for 3+ years, grandfathers legacy subscriber rates, encourages password sharing, and distributes profits to all contributors including unsuccessful auditionees. Estimated to have reached 50-67% penetration of total addressable market.
+- **2025-10-01** — Crossed 1M paid subscribers (31% YoY growth); launched $129.99/year superfan tier at fan demand; Game Changer S7 premiere reached 1M views in 2 weeks (most-watched episode ever); ARR north of $30M with 40-45% EBITDA margins
 ## Relationship to KB
 
 - [[creator-owned-streaming-infrastructure-has-reached-commercial-scale-with-430M-annual-creator-revenue-across-13M-subscribers]]

inbox/archive/.extraction-debug/2025-01-01-jmir-digital-engagement-glp1-weight-loss-outcomes.json

@@ -0,0 +1,26 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 1,
+    "kept": 0,
+    "fixed": 3,
+    "rejected": 1,
+    "fixes_applied": [
+      "digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:set_created:2026-03-16",
+      "digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:stripped_wiki_link:glp-1-persistence-drops-to-15-percent-at-two-years-for-non-d",
+      "digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:stripped_wiki_link:GLP-1 receptor agonists are the largest therapeutic category"
+    ],
+    "rejections": [
+      "digital-behavioral-support-combined-with-glp1-achieves-44-percent-greater-weight-loss-than-medication-alone-while-halving-drug-requirements.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-16"
+}

inbox/archive/.extraction-debug/2025-10-01-variety-dropout-superfan-tier-1m-subscribers.json

@@ -0,0 +1,34 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "voluntary-premium-tiers-succeed-when-fans-have-intrinsic-motivation-to-fund-platform-survival.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    },
+    {
+      "filename": "creator-owned-platforms-form-collaborative-ecosystems-not-zero-sum-competition-when-creators-multi-home-across-owned-infrastructure.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 2,
+    "kept": 0,
+    "fixed": 4,
+    "rejected": 2,
+    "fixes_applied": [
+      "voluntary-premium-tiers-succeed-when-fans-have-intrinsic-motivation-to-fund-platform-survival.md:set_created:2026-03-16",
+      "voluntary-premium-tiers-succeed-when-fans-have-intrinsic-motivation-to-fund-platform-survival.md:stripped_wiki_link:community-ownership-accelerates-growth-through-aligned-evang",
+      "voluntary-premium-tiers-succeed-when-fans-have-intrinsic-motivation-to-fund-platform-survival.md:stripped_wiki_link:the-media-attractor-state-is-community-filtered-IP-with-AI-c",
+      "creator-owned-platforms-form-collaborative-ecosystems-not-zero-sum-competition-when-creators-multi-home-across-owned-infrastructure.md:set_created:2026-03-16"
+    ],
+    "rejections": [
+      "voluntary-premium-tiers-succeed-when-fans-have-intrinsic-motivation-to-fund-platform-survival.md:missing_attribution_extractor",
+      "creator-owned-platforms-form-collaborative-ecosystems-not-zero-sum-competition-when-creators-multi-home-across-owned-infrastructure.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-16"
+}

inbox/archive/.extraction-debug/2026-02-01-cms-balance-model-details-rfa-design.json

@@ -0,0 +1,32 @@
+{
+  "rejected_claims": [
+    {
+      "filename": "cms-balance-capitation-adjustment-plus-reinsurance-removes-structural-barriers-to-glp1-coverage.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    },
+    {
+      "filename": "manufacturer-funded-lifestyle-support-shifts-behavioral-intervention-costs-from-payers-to-drugmakers.md",
+      "issues": [
+        "missing_attribution_extractor"
+      ]
+    }
+  ],
+  "validation_stats": {
+    "total": 2,
+    "kept": 0,
+    "fixed": 2,
+    "rejected": 2,
+    "fixes_applied": [
+      "cms-balance-capitation-adjustment-plus-reinsurance-removes-structural-barriers-to-glp1-coverage.md:set_created:2026-03-16",
+      "manufacturer-funded-lifestyle-support-shifts-behavioral-intervention-costs-from-payers-to-drugmakers.md:set_created:2026-03-16"
+    ],
+    "rejections": [
+      "cms-balance-capitation-adjustment-plus-reinsurance-removes-structural-barriers-to-glp1-coverage.md:missing_attribution_extractor",
+      "manufacturer-funded-lifestyle-support-shifts-behavioral-intervention-costs-from-payers-to-drugmakers.md:missing_attribution_extractor"
+    ]
+  },
+  "model": "anthropic/claude-sonnet-4.5",
+  "date": "2026-03-16"
+}

inbox/archive/2025-01-01-jmir-digital-engagement-glp1-weight-loss-outcomes.md

@@ -7,9 +7,13 @@ date: 2025-01-01
 domain: health
 secondary_domains: []
 format: study
-status: unprocessed
+status: enrichment
 priority: high
 tags: [glp-1, adherence, digital-health, weight-loss, tirzepatide, behavioral-support, obesity]
+processed_by: vida
+processed_date: 2026-03-16
+enrichments_applied: ["glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics.md", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -60,3 +64,12 @@ A retrospective cohort service evaluation study published in the Journal of Medi
 PRIMARY CONNECTION: GLP-1 cost-effectiveness under capitation requires solving the adherence paradox (March 12 claim candidate)
 WHY ARCHIVED: Convergent evidence that digital behavioral support partially solves the GLP-1 adherence problem — changes the economic model under capitation if sustained
 EXTRACTION HINT: Focus on the half-dose finding (cost efficiency) and the convergence with WHO guidelines (behavioral combination is now international standard). Scope carefully — observational, not RCT.
+
+
+## Key Facts
+- Voy platform components include live group video coaching, text-based support, educational content, weight monitoring, and adherence tracking
+- UK Voy study showed high withdrawal rate in non-engaged group limiting generalizability
+- Tirzepatide users outperformed semaglutide users: 13.9% vs 9.5% at 5 months in Voy cohort
+- WHO December 2025 guidelines recommend combining GLP-1 with intensive behavioral therapy
+- Danish study was 64 weeks duration, UK Voy study was 5 months
+- All three studies (UK, Danish, Wiley) were retrospective/observational, not RCTs

inbox/archive/2025-02-01-deadline-pudgy-penguins-youtube-series.md

@@ -7,9 +7,13 @@ date: 2025-02-01
 domain: entertainment
 secondary_domains: [internet-finance]
 format: article
-status: unprocessed
+status: enrichment
 priority: medium
 tags: [pudgy-penguins, lil-pudgys, youtube, animated-series, thesoul-publishing, community-ip-distribution]
+processed_by: clay
+processed_date: 2026-03-16
+enrichments_applied: ["youtube-first-distribution-for-major-studio-coproductions-signals-platform-primacy-over-traditional-broadcast-windowing.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -49,3 +53,12 @@ PRIMARY CONNECTION: [[entertainment IP should be treated as a multi-sided platfo
 WHY ARCHIVED: Secondary source confirming Lil Pudgys launch details; the 13K→millions trajectory data point.
 
 EXTRACTION HINT: Use as supplementary evidence. The primary archive for the Lil Pudgys quality tension is `2025-02-01-animation-magazine-lil-pudgys-launch-thesoul.md`.
+
+
+## Key Facts
+- Pudgy Penguins YouTube channel had 13,000 subscribers at Lil Pudgys series launch (Spring 2025)
+- Lil Pudgys series: 1,000+ minutes of animation, 5-minute episodes, 2/week release cadence
+- TheSoul Publishing: 2B+ social media followers, known for 5-Minute Crafts
+- Pudgy Penguins retail metrics at announcement: $10M+ toy sales, 2M+ units, 3,100+ Walmart stores, 7,000+ retail locations
+- Pudgy Penguins GIPHY views surpassing Hello Kitty and Pokémon (50B+ by announcement date)
+- By 2026, Lil Pudgys episodes garnering millions of views per episode (per DappRadar)

inbox/archive/2025-06-01-abridge-valuation-growth-ai-scribe-metrics.md

@@ -7,9 +7,13 @@ date: 2025-06-01
 domain: health
 secondary_domains: []
 format: company-analysis
-status: unprocessed
+status: enrichment
 priority: high
 tags: [abridge, ai-scribe, ambient-documentation, clinical-ai, health-tech, valuation, epic, health-systems]
+processed_by: vida
+processed_date: 2026-03-16
+enrichments_applied: ["AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output.md", "AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk.md", "AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -69,3 +73,18 @@ As of mid-2025, Abridge has become the dominant standalone ambient AI documentat
 PRIMARY CONNECTION: [[AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output]]
 WHY ARCHIVED: Validates AI-native productivity thesis with real metrics, but the Epic AI Charting threat (February 2026) creates a stress test of whether documentation-first positioning is durable
 EXTRACTION HINT: The Abridge metrics validate the productivity claim; archive this alongside the Epic AI Charting source and let the extractor decide whether they confirm or complicate the "beachhead" thesis together
+
+
+## Key Facts
+- Abridge reached $60M ARR at end of 2024
+- Abridge reached $100M ARR by May 2025
+- Abridge contracted ARR was $117M in Q1 2025
+- Abridge raised $550M total in 2025 including a $300M Series E
+- Abridge valuation reached $5.3B in mid-2025, doubling in 4 months
+- Abridge has 150+ publicly disclosed health system customers as of mid-2025
+- Kaiser Permanente deployed Abridge to 24,600 physicians across 40 hospitals and 600 clinics
+- Mayo Clinic deployed Abridge to 2,000+ physicians enterprise-wide
+- Abridge won top ambient AI slot in 2025 KLAS annual report
+- Epic launched AI Charting in February 2026
+- BVP State of Health AI 2026 reports 92% of provider health systems deploying/implementing/piloting ambient AI as of March 2025
+- Early adopters report 10-15% revenue capture improvements through better coding and documentation

inbox/archive/2025-10-01-variety-dropout-superfan-tier-1m-subscribers.md

@@ -7,9 +7,13 @@ date: 2025-10-01
 domain: entertainment
 secondary_domains: []
 format: article
-status: unprocessed
+status: enrichment
 priority: medium
 tags: [dropout, owned-streaming, superfan, subscription, distribution-graduation, creator-economy, sam-reich]
+processed_by: clay
+processed_date: 2026-03-16
+enrichments_applied: ["creator-owned-streaming-infrastructure-has-reached-commercial-scale-with-430M-annual-creator-revenue-across-13M-subscribers.md", "indie-streaming-platforms-emerged-as-category-by-2024-with-convergent-structural-patterns-across-content-verticals.md", "creator-owned-streaming-uses-dual-platform-strategy-with-free-tier-for-acquisition-and-owned-platform-for-monetization.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -68,3 +72,16 @@ PRIMARY CONNECTION: [[the media attractor state is community-filtered IP with AI
 WHY ARCHIVED: Confirms distribution graduation pattern AND introduces a new mechanism (voluntary premium tier) that shows community economics operating without blockchain infrastructure. The cross-platform Brennan Lee Mulligan deal challenges the simple "rightward migration" framing.
 
 EXTRACTION HINT: Two distinct claims deserve extraction: (1) the voluntary premium tier as community economics mechanism (Dropout data shows fans willing to over-pay for survival/growth of platforms they love), and (2) the owned-platform ecosystem formation (Dropout + Beacon collaboration) as a more nuanced pattern than pure platform independence. Don't just confirm prior claims — these nuances matter.
+
+
+## Key Facts
+- Dropout reached 1 million paid subscribers in October 2025
+- Dropout subscriber growth was 31% from 2024 to 2025
+- Dropout's superfan tier costs $129.99/year vs $6.99/month standard tier
+- Game Changer Season 7 premiere reached 1M views in first 2 weeks
+- Dropout has 40 employees with ARR north of $30M
+- Dropout operates at 40-45% EBITDA margins
+- Critical Role's Beacon launched May 2024 at $5.99/month
+- Critical Role lost ~20% of Twitch subscribers after Beacon launch
+- Dropout subscriber base grew 600% over 3 years (2021-2024)
+- CollegeHumor YouTube channel had 15M+ subscribers before Dropout pivot

inbox/archive/2025-11-01-ambient-ai-scribe-burnout-reduction-rct.md

@@ -7,9 +7,12 @@ date: 2025-11-01
 domain: health
 secondary_domains: [ai-alignment]
 format: study
-status: unprocessed
+status: enrichment
 priority: medium
 tags: [ai-scribe, burnout, physician-wellbeing, clinical-ai, ambient-documentation, randomized-trial, documentation-burden]
+processed_by: vida
+processed_date: 2026-03-16
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -57,3 +60,17 @@ Two studies published in late 2025 examining ambient AI scribe effects on physic
 PRIMARY CONNECTION: [[ambient AI documentation reduces physician documentation burden by 73 percent but the relationship between automation and burnout is more complex than time savings alone]]
 WHY ARCHIVED: This source updates the existing claim with burnout evidence — the "relationship is more complex than time savings alone" is now empirically supported. The mechanism (cognitive load + patient connection) is the key insight.
 EXTRACTION HINT: The extractor should update the existing KB claim rather than creating a new one — add the burnout finding, the mechanism (cognitive load not just time), and note the RCT evidence
+
+
+## Key Facts
+- Multi-site observational study included 263 physicians across 6 US health systems (mix of academic and community)
+- Burnout rate dropped from 51.9% to 38.8% among ambient AI scribe users
+- 74% lower odds of experiencing burnout with ambient AI scribes
+- 8.5% reduction in total EHR time among users vs matched controls
+- 15%+ decrease in time spent composing notes
+- 78% increase in undivided patient attention (one health system survey, 200+ clinicians)
+- 61% reduction in cognitive load
+- 77% increase in work satisfaction
+- 35% decrease in after-hours documentation
+- Advisory.com analysis (Feb 2026): roughly one-third of providers currently have access to ambient AI scribes
+- WVU Medicine expansion occurred March 2026 across 25 hospitals

inbox/archive/2026-01-01-bvp-state-of-health-ai-2026.md

@@ -7,9 +7,13 @@ date: 2026-01-01
 domain: health
 secondary_domains: []
 format: industry-report
-status: unprocessed
+status: enrichment
 priority: high
 tags: [health-ai, ai-native, revenue-productivity, ambient-scribes, clinical-ai, market-analysis, venture-capital]
+processed_by: vida
+processed_date: 2026-03-16
+enrichments_applied: ["AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output.md", "AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk.md", "healthcare AI funding follows a winner-take-most pattern with category leaders absorbing capital at unprecedented velocity while 35 percent of deals are flat or down rounds.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -63,3 +67,13 @@ Comprehensive annual landscape analysis of AI in healthcare from Bessemer Ventur
 PRIMARY CONNECTION: [[AI-native health companies achieve 3-5x the revenue productivity of traditional health services because AI eliminates the linear scaling constraint between headcount and output]]
 WHY ARCHIVED: Primary source for the existing KB productivity claim, plus the scope qualification issue on the 92% adoption figure
 EXTRACTION HINT: Note the scope qualification needed — 92% "deploying/implementing/piloting" vs. active deployment is a meaningful distinction. The extractor should flag this when reviewing the existing KB claim.
+
+
+## Key Facts
+- Traditional healthcare services: $100-200K ARR per FTE
+- Healthcare SaaS (pre-AI): $200-400K ARR per FTE
+- AI-native healthcare: $500K-$1M+ ARR per FTE
+- AI-native healthcare companies achieve 70-80%+ software-like margins
+- As of March 2025: 92% of provider health systems deploying, implementing, or piloting ambient AI
+- Early ambient AI adopters report 10-15% revenue capture improvements through better coding and documentation in year 1
+- Health tech companies hitting $100M+ ARR in under 5 years represents compression of time-to-scale

inbox/archive/2026-02-01-cms-balance-model-details-rfa-design.md

@@ -7,9 +7,13 @@ date: 2026-01-08
 domain: health
 secondary_domains: [internet-finance]
 format: policy-document
-status: unprocessed
+status: enrichment
 priority: high
 tags: [balance-model, cms, glp-1, capitation, medicaid, medicare, value-based-care, lifestyle-support, manufacturer, adherence]
+processed_by: vida
+processed_date: 2026-03-16
+enrichments_applied: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035.md", "glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -68,3 +72,13 @@ This is CMS explicitly designing around the misalignment I identified in March 1
 PRIMARY CONNECTION: [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
 WHY ARCHIVED: The BALANCE model's specific payment mechanism (capitation adjustment + reinsurance) is a direct policy response to the identified VBC misalignment — this design detail changes the analysis from "BALANCE is just drug coverage" to "BALANCE is structural incentive redesign"
 EXTRACTION HINT: Focus on the dual payment mechanism as the structural innovation, not the drug access expansion (which is the headline but not the analytically important insight)
+
+
+## Key Facts
+- BALANCE Model eligibility requires BMI thresholds per FDA labeling plus evidence of metabolic dysfunction (heart failure, uncontrolled hypertension, pre-diabetes)
+- Prior authorization requirements are negotiated with manufacturers, not blanket coverage
+- Manufacturers must reach 'Key Terms' agreement with CMS to become model participants
+- Medicare GLP-1 Bridge launches July 2026, earlier than full BALANCE rollout
+- Bridge provides access to manufacturer-negotiated prices before full model launches
+- State and plan participation is voluntary, creating potential adverse selection risk
+- 9.5% average body weight reduction is the manufacturer eligibility threshold

inbox/archive/2026-03-11-wvu-abridge-rural-health-systems-expansion.md

@@ -7,9 +7,13 @@ date: 2026-03-11
 domain: health
 secondary_domains: []
 format: news
-status: unprocessed
+status: enrichment
 priority: medium
 tags: [abridge, ambient-scribe, rural-health, clinical-ai, health-systems, access, workforce]
+processed_by: vida
+processed_date: 2026-03-16
+enrichments_applied: ["AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk.md", "ambient AI documentation reduces physician documentation burden by 73 percent but the relationship between automation and burnout is more complex than time savings alone.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content
@@ -48,3 +52,9 @@ West Virginia University Medicine (WVU Medicine) announced the expansion of the
 PRIMARY CONNECTION: [[AI scribes reached 92 percent provider adoption in under 3 years because documentation is the rare healthcare workflow where AI value is immediate unambiguous and low-risk]]
 WHY ARCHIVED: Rural expansion suggests ambient AI is beyond early-adopter phase; also implicit validation that Abridge maintained competitive position despite Epic entry
 EXTRACTION HINT: Supporting evidence for adoption trajectory and competitive position — not a standalone claim source
+
+
+## Key Facts
+- WVU Medicine serves West Virginia, one of the most rural and medically underserved states in the US
+- WVU Medicine announced expansion on March 11, 2026, one month after Epic AI Charting launch in February 2026
+- The expansion covers 25 hospitals including rural facilities